No other interest can take precedence - a patient's perspective on oncology drug development

Nat Rev Clin Oncol. 2019 Aug;16(8):461-462. doi: 10.1038/s41571-019-0230-4.

Author

Bettina Ryll^{1

2}

Affiliations

¹ Melanoma Patient Network Europe, Uppsala, Sweden. bettina.ryll@mpneurope.org.
² Department of Organismal Biology, Uppsala University, Uppsala, Sweden. bettina.ryll@mpneurope.org.

PMID: 31110270
DOI: 10.1038/s41571-019-0230-4

No abstract available

Publication types

Personal Narrative

MeSH terms

Drug Development*
Humans
Medical Oncology*